APA (7th ed.) Citation

KD, B., S, C., GJ, C., AR, D., M, K., JA, G., & CR, B. (2020). Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. European journal of nuclear medicine and molecular imaging, 47(4), 759. https://doi.org/10.1007/s00259-019-04429-x

Chicago Style (17th ed.) Citation

KD, Bosch, Chicklore S, Cook GJ, Davies AR, Kelly M, Gossage JA, and Baker CR. "Staging FDG PET-CT Changes Management in Patients with Gastric Adenocarcinoma Who Are Eligible for Radical Treatment." European Journal of Nuclear Medicine and Molecular Imaging 47, no. 4 (2020): 759. https://doi.org/10.1007/s00259-019-04429-x.

MLA (9th ed.) Citation

KD, Bosch, et al. "Staging FDG PET-CT Changes Management in Patients with Gastric Adenocarcinoma Who Are Eligible for Radical Treatment." European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 4, 2020, p. 759, https://doi.org/10.1007/s00259-019-04429-x.